INSIGHTS ON LIQUID DOSE MANUFACTURING
-
![GettyImages-2235582013-prefilled-syringe-liquid-manufacturing]( "Ensuring Integrity: Testing Viscous Biologics In Pre-Filled Syringes")
Ensuring Integrity: Testing Viscous Biologics In Pre-Filled SyringesViscous biologics in pre-filled syringes demand precise integrity testing. Discover how advanced HVLD technology detects micro-defects and ensures sterility, meeting stringent USP <1207> standards.
-
![GettyImages-2216788272-food-inspection-production-line]( "The Fill/Finish Timeline: What Comes After Manufacturing")
The Fill/Finish Timeline: What Comes After ManufacturingThe post-manufacturing backend of sterile injectable fill-finish operates in a strict sequence—encompassing inspection, testing, QA review, and complex labeling validation—requiring early planning to avoid timeline delays.
-
![pharma-spray-drying-GettyImages-1746637448]( "Spray Dried Biologics For Injectable Dosage Forms")
Spray Dried Biologics For Injectable Dosage FormsSpray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.
-
![GettyImages-1316723095-vial]( "What Does Annex 1 Mean For Cryovial Filling?")
What Does Annex 1 Mean For Cryovial Filling?New sterile manufacturing rules require major changes to cryovial filling. Ensure compliance by adopting better "first-air" protection, minimizing human contact, and using 100% dose checks.
-
Enhancing Biological Indicators With Enzyme Indicators6/30/2026
Achieve greater process assurance in decontamination cycles. Combining traditional indicators with rapid, quantitative enzyme data reveals performance trends to optimize validation.
-
Balancing Biologic Limitations And Patient Perceptions For An Enhanced Injection Experience11/4/2024
Discover an innovative sTW needle design reduces injection force and pain, enhancing comfort and ease for chronic patients while promoting long-term adherence through improved injection experiences.
-
CAR-T Cell Therapy For Cancer: The Patient's In The Process7/21/2026
Autologous cell therapies require absolute process repeatability. Learn how automated cryovial filling protects cell viability and eliminates manual variability.
-
Protecting Your Drug Product5/13/2026
With patient lives depending on every dose, even minor vulnerabilities in containment or delivery systems can have serious consequences for product integrity and patient outcomes.
-
Cost-Effective Strategies For Sterile Injectable Outsourcing6/11/2025
Explore how CMOs are playing a pivotal role in enabling pharmaceutical companies to optimize their operations and how this collaboration is reshaping the future of pharmaceutical manufacturing.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
![Dec Group - containment solutions]( "Containment Solution Technologies")
Discover end-to-end containment solutions for bulk handling, isolator technology, and sterile processing that prioritize safety, efficiency, and innovation in hazardous material handling.
-
![ASEPTiCell]( "Isolator Barrier Pharmaceutical Aseptic Filling Systems")
ASEPTiCell is integrated with isolator-barrier technologies to fully enclose and tightly control the aseptic environment for ideal conditions for processing sterile drug products. The system can be configured with a Restricted Access Barrier System (RABS) or an aseptic isolator to provide uninterrupted aseptic conditions during production. With isolator integrated systems, the ASEPTiCell is completely compatible with repeated in-situ bio-decontamination using hydrogen peroxide to further enhance the sterility assurance of the system.
-
![ASEPTiCell ScreenShot 3]( "Aseptic Filling Systems For Biopharmaceutical Manufacturing")
AST aseptic filling products address the unique processing requirements of biologics manufacturing to gently care for biologic products during the fill-finish process. Their highly accurate peristaltic dosing system uses single-use pharmaceutical grade tubing that has been optimized to keep shear stress to an absolute minimum. When exiting the fluid path through the filling needle, the motion control system maintains the fill needle within the container and slowly rises as the product is being dispensed to minimize splashing and foaming that could introduce stress to the product. Temperature controlled filling is also possible with the ASEPTiCell® and GENiSYS® systems. AST has experience dosing products at temperatures as low as 3°C.
-
![AST - Atmos]( "Atmos Isolator For Fill/Finish Applications")
A technically superior, cGMP-compliant product, the AST Atmos Isolator features a groundbreaking user-friendly design, enhanced automation and efficiency, robust sterility assurance, and a disruptive VPHP solution providing industry-leading bio-decontamination cycle times.
-
![GettyImages-2166607928_aseptic fill finish]( "Aseptic Fill Finish")
Our comprehensive inspection systems, designed to adhere to the strictest regulatory standards, offer robust quality assurance, safeguarding the integrity of your product from development through to market.
